BOT 2.63% 37.0¢ botanix pharmaceuticals ltd

Nothing has changed!, page-23

  1. 324 Posts.
    lightbulb Created with Sketch. 91
    instruction approval yes.

    clinical is done.

    notwithstanding the delay, breaking this outcome into its constituent parts, one can argue the approval process is largely de-risked now.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.